To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Clinical trial NCT05908084 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05908084
- Sponsor
- Humacyte, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-07
- Primary completion
- 2027-06-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.